Multivariable logistic regressions for predictors of receipt of chemotherapy in pathological stage I-III HR+HER2- breast cancer patients with 1 – 3 positive nodes, NCDB 2004-2018. This evidence concerns the gene ERBB2 and breast carcinoma.